# Vasopressor Prophylaxis After Spinal Anesthesia

> **NCT03234816** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 270 (actual)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Norepinephrine 0.05 mcg /Kg/min
- **DRUG:** Norepinephrine 0.1 mcg /Kg/min
- **DRUG:** Norepinephrine 0.15 mcg /Kg/min
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03234816
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-02
- **Primary completion:** 2018-11-02
- **Final completion:** 2018-12-10
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2019-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03234816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03234816, "Vasopressor Prophylaxis After Spinal Anesthesia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03234816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*